Practice software links expand; Florfinasone enters US distribution

|11 min read
Female veterinarian sits at a desk using PIMS in a vet clinic exam room.

Theme this week

Synchrony, Antech and Instinct announced links for clinic payments and records. Their value depends on total staff time, including manual entries and checks. This month, clinics should measure time spent on the whole task before expanding use or changing staff plans.

Executive takeaways

  1. Compare full Florfinasone Otic quotes for the same expected use after clinical review, before the next drug order. Cronus announced US distribution on October 1. 1 The US Food and Drug Administration (FDA) approved the drug on April 8. 2 Local stock is unconfirmed.
  2. Compare total checkout time with and without CareCredit’s link during any Vetspire trial this month. Synchrony announced the link on September 30. Rollout was still in progress at that point. 3
  3. Compare total staff time for the same tests with and without Antech’s reader during any trial this month. Antech says its trūRapid Reader captures images of supported screening tests at 10 minutes. Staff still review and confirm each result. 4
  4. Confirm reports reach correct patient records with less staff time than manual filing before expanding the Instinct–SignalPET trial. Instinct says the link returns some types of completed imaging reports. 5 Setup and checks could reduce time saved.
  5. Compare record errors and total staff time for each task with and without artificial intelligence (AI) before changing staffing. Some users in Digitail’s survey said they moved data by hand. 6, 7 Errors could add work to check and fix records.

Signals

1. Cronus launches Florfinasone Otic through US distributors

OBSERVED

Cronus Pharma announced US distribution of Florfinasone Otic on October 1, 2026. 1 The FDA approved the drug on April 8, 2026. The approval covers certain outer ear infections in dogs. 2

VIEWPOINT

The launch gives clinics another buying option after a clinical lead confirms the drug suits their patients. Its value depends on full costs and reliable delivery of the amount the clinic expects to use. Different pack sizes or unused stock could outweigh a lower quoted price.

Compare full quotes for amounts that meet the same expected need. Maintain current orders while the clinical review, supplier terms or arrival dates are unclear.

CONFIDENCE

High — Company and FDA records support the launch and approval. Local stock availability is unknown.

ACTIONS

Independent veterinary practices

  • Request a Florfinasone quote showing pack size and fees before the clinic’s next drug order.
  • Ask the clinical lead to review Florfinasone’s approved use before changing the buying list.

Corporate veterinary groups and clinic consolidators

  • Compare full Florfinasone quotes for the same expected use after clinical review, before the next group buying review.
  • Check Florfinasone delivery dates for each clinic before placing a group order.

Distributors, e-retail and home delivery providers

  • Check Florfinasone stock in each warehouse before confirming a clinic order through the announced launch.
  • Give account teams confirmed Florfinasone arrival dates before their next calls to clinics.

Manufacturers and commercial operators

  • Log buyers’ Florfinasone price and supply questions during this month’s dog ear medicine account calls.
  • Check claims comparing Florfinasone with other drugs before the next sales briefing.

3. Antech adds timed image capture to rapid tests

OBSERVED

Antech announced the North American launch of its trūRapid Reader on October 5, 2026. The company says the reader takes an image of a supported dog or cat screening test at 10 minutes. Staff review and confirm the result before it goes to linked practice software. Staff can also read the tests by eye without the reader. 4

VIEWPOINT

Antech’s reader could reduce the work needed to record test results. That depends on whether image capture and the software link replace staff tasks.

Few tests, setup work or extra checks could leave little time saved for the equipment cost. Before buying, clinics should compare the total work with their current process. They should also obtain full costs and software requirements.

CONFIDENCE

High — Antech’s release states the launch and features. Clinic use is unknown.

ACTIONS

Independent veterinary practices

  • Check whether Antech’s reader links to the clinic’s software before seeking a quote for use with supported tests.
  • Compare total staff time with and without the reader for the same tests during this month’s trial.

Corporate veterinary groups and clinic consolidators

  • Choose trial clinics using supported tests with different test counts and software before requesting a group trial.
  • Set a cost limit and minimum time saving before expanding any Antech reader trial.

Distributors, e-retail and home delivery providers

  • Check rights to sell Antech’s reader before listing it for clinics.
  • Name a setup contact for the reader’s supported software before offering it to clinics.

Manufacturers and commercial operators

  • Compare supported tests and software links with current products at this month’s equipment review.
  • Ask clinic partners how staff confirm test results before planning a new reader link.

5. Digitail survey finds manual work between clinic systems

OBSERVED

Digitail released its survey results on AI on October 1, 2026. 6 Of 1,171 AI users who described how most AI tools link to their practice software, 57% reported moving some data by hand. The question covered people who used practice software at their clinic and excluded those unsure about the link. 7

Digitail sells AI practice software. It initiated the study and helped design it. The American Animal Hospital Association (AAHA) ran it from July 27 to August 12, 2026. The online survey drew 1,730 volunteers from both organizations’ networks in the United States and Canada. Recruitment used email and social media. The sample included clinical staff, students and people working in the industry. 7

The findings rely on what people said at one point in time. The survey gives no measured task times or separate US results. 7

VIEWPOINT

Copying data manually adds staff time and creates chances for human error. Staff could miss details, copy old data or file information in the wrong patient record. Those errors could affect billing, follow-up or later work and add further time for quality control checks and fixes.

Time saved elsewhere could still make a tool worth using. Clinics should compare record accuracy and total staff time for the same tasks with and without AI before wider use. That comparison should include time spent checking and fixing records.

CONFIDENCE

Moderate — The report gives methods and counts. The findings rely on volunteers’ own reports.

ACTIONS

Independent veterinary practices

  • Check data moved by hand against source records and patient details during this month’s AI trial.
  • Compare total staff time for the same task with and without AI before changing next month’s staff plan.

Corporate veterinary groups and clinic consolidators

  • Group AI trial clinics by task and software before comparing results this month.
  • Compare staff time and record errors for the same tasks with and without AI before expanding use.

Distributors, e-retail and home delivery providers

  • Record clinic accounts’ questions about manual AI data entry during this month’s account calls.
  • Route questions about data transfer checks to the clinic’s software providers during this month’s account calls.

Manufacturers and commercial operators

  • Show clinic buyers how staff check data moved by hand in this month’s AI sales demonstrations.
  • Compare total staff time for the same task with and without AI before briefing sales teams on savings.

Methodology and governance

This PULSE Edition covers developments posted or acted on from September 30, through October 7, 2026, using US Eastern Time.

OBSERVED statements are anchored to public sources and attributed subscriber reports cited below. VIEWPOINT statements present PETMETRIX assessments of their commercial implications. Early watch items are early hypotheses. They are not yet strong enough for a full Signal, and they include what would confirm or rule out the pattern.

PETMETRIX PULSE commercial intelligence is provided for informational use and to support lawful, independent business decisions. It is not legal, clinical, reimbursement, accounting, or financial advice. Route legal, clinical, reimbursement, accounting, and financial decisions to qualified advisers. Respect for the veterinary-client-patient relationship is mandatory.

Terms of Service | Privacy Policy | Methodology and Data Disclaimer

Glossary

Confidence: PETMETRIX rating of the strength and consistency of a signal. It is expressed as High, Moderate, or Low and does not mean certainty.

Observed: A statement anchored in an attributable source, for example a company announcement, regulator posting, publication, data release, or market report.

Otic: Relating to the ear; used to describe medicines applied in the ear.

Practice software: Practice information management system (PIMS) software a veterinary practice uses to manage medical records, appointments, invoices, products, and workflow.

Screening test: A test used to look for possible disease, often before symptoms appear.

Signal: A sourced market, company, product, policy, data, or behavior change with a clear commercial implication.

Software link: A connection that lets separate software systems share data or features.

Viewpoint: PETMETRIX interpretation of observed facts through a commercial lens.

Volunteer sample: A study group formed from people who choose to join through an open invitation.

References

  1. Cronus Pharma LLC. “Cronus Pharma Announces the Launch of Florfinasone™ Otic for the Treatment of Otitis Externa in Dogs.” Company press release distributed by Business Wire, October 1, 2026. https://www.businesswire.com/news/home/20261001933459/en/Cronus-Pharma-Announces-the-Launch-of-Florfinasone-Otic-for-the-Treatment-of-Otitis-Externa-in-Dogs
  2. US Food and Drug Administration. “Recent Animal Drug Approvals.” n.d.; Florfinasone Otic approval entry dated April 8, 2026; accessed October 8, 2026. https://www.fda.gov/animal-veterinary/approved-animal-drug-products-green-book/recent-animal-drug-approvals
  3. Synchrony. “CareCredit Partners with AI-Enabled Veterinary Practice Solution Vetspire to Modernize Payments.” Press release, September 30, 2026. https://www.synchrony.com/contenthub/newsroom/carecredit-partners-with-vetspire.html
  4. Antech Diagnostics. “Antech™ Introduces trūRapid™ Reader in North America to Support trūRapid Portfolio.” Press release, October 5, 2026. https://www.antechdiagnostics.com/2026/10/05/antech-introduces-trurapid-reader-in-north-america-to-support-trurapid-portfolio/
  5. Instinct Science. “Instinct + SignalPET: A More Connected Radiology Workflow.” Company blog post, October 5, 2026. https://instinct.vet/blog/instinct-emr-signalpet-radiology-integration/
  6. Digitail Team. “The State of AI in Veterinary Medicine: 2026 Digitail and AAHA Study.” Research-summary article, October 1, 2026. https://digitail.com/blog/the-state-of-ai-in-veterinary-medicine-2026-digitail-and-aaha-study/
  7. Digitail. “2026 State of AI in Veterinary Medicine: From Experimentation to Value.” Survey report, conducted with the American Animal Hospital Association, 2026. https://4912130.fs1.hubspotusercontent-na1.net/hubfs/4912130/2026%20State%20of%20AI%20in%20Veterinary%20Medicine.pdf